Balfaxar Powder, For Solution
Product Images NDC 68982-261

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Balfaxar (NDC 68982-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

An instructional illustration showing a hand holding a vial with a transfer device attached on top. Another hand is lifting the cap of the transfer device. The device is labeled 'Transfer Device.' This diagram likely depicts the initial step in preparing a solution using the transfer device.*

FDA Label Image

Image File (Img0002)

An instructional illustration showing a vial labeled 'Diluent Vial' with liquid inside and an arrow pointing downward toward the vial from an upside-down cap or container with blue liquid droplets, indicating a mixing or combination step for reconstitution.*

FDA Label Image

Image File (Img0003)

An instructional diagram showing a vial labeled "Diluent Vial" below a blue vial with measurement markings. Above these two vials is an arrow pointing upward below a flip-off cap, indicating removal of the cap from the vial. This likely illustrates preparation steps for reconstituting a powder with the diluent.*

FDA Label Image

Image File (Img0004)

An instructional illustration showing two vials stacked vertically. The top vial is labeled 'Diluent Vial' and the bottom vial is labeled 'Lyophilized Powder Vial.' A downward arrow between them indicates the diluent is to be transferred into the powder vial, suggesting the preparation step for intravenous solution reconstitution.*

FDA Label Image

Image File (Img0005)

An instructional illustration for reconstituting Balfaxar intravenous powder for solution. It shows an empty diluent vial above and a reconstituted product vial below with arrows indicating the diluent is added to the product vial and mixed by rotation.*

FDA Label Image

Image File (Img0006)

An instructional illustration showing how to attach a syringe to a vial labeled 'Reconstituted Product Vial.' The image demonstrates pushing down and twisting the syringe onto the vial for proper use.*

FDA Label Image

Image File (Img0007)

An instructional illustration depicting a reconstituted product vial connected to a syringe for intravenous administration. The image shows the syringe being drawn from the vial, labeled as 'Reconstituted Product Vial.' No specific product branding or dosage information is visible.*

FDA Label Image

Image File (Img0008)

An instructional illustration showing an empty product vial being removed or separated from a syringe. The vial is depicted above the syringe with an upward arrow indicating detachment, and a curved arrow shows rotation of the syringe part. Labeled with the text 'Empty Product Vial.'*

FDA Label Image

Image File (Img0009)

A data table showing virus reduction factors (log base 10) for enveloped and non-enveloped viruses at different production steps (S/D-treatment and nanofiltration) for the product Balfaxar. It includes specific virus types: HIV-1, BVDV, PRV, HAV, and PPV, with corresponding reduction values for each step and a global reduction factor summary.*

FDA Label Image

Image File (Img0010)

Packaging label for Balfaxar 500 IU Range Prothrombin Complex Concentrate (Human) powder for solution, intravenous use. The label includes dosage strength, manufacturer Octapharma USA Inc, and storage instructions. It details contents of each vial and notes the product is sterile, preservative-free, and for intravenous administration only.*

FDA Label Image

Image File (Img0011)

Packaging label for Balfaxar, Prothrombin Complex Concentrate Human-llans, a plasma derivative in powder form for solution for intravenous use. The label indicates a 1000 IU range strength and includes detailed information on the vial's contents, manufacturer Octapharma Pharmzeutika Produktionsges.m.b.H. in Vienna, and distributor Octapharma USA Inc. The label also provides storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.